AMICUS THERAPEUTICS, INC. — Director's Dealing 2016

Jun 13, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2016-06-09

Reporting Person: ESSNER ROBERT (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-06-09	Stock Options (right to buy)	$6.71	A	20000	Acquired	2026-06-09	Common Stock (20000)	Direct

Footnotes

F1: One hundred percent of the shares subject to this option will vest and become exercisable on the date of the annual meeting of the stockholders of the issuer to be held in 2017.